Skip to content

Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer

The Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer: A Double Blind Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05009693
Enrollment
72
Registered
2021-08-17
Start date
2019-05-01
Completion date
2020-06-20
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related Fatigue, Light; Therapy, Complications

Keywords

Cancer-related fatigue, White light therapy, Chemotherapy, Clinical trial

Brief summary

White light therapy is one of the non-pharmacological methods in the management of fatigue. Cancer-related fatigue (CRF) is a persistent, subjective sense of physical, emotional, and/or cognitive tiredness or burnout. It is associated with cancer or cancer treatment from the first diagnosis until the end of life that is not proportional to recent physical activity. It was founded that 10,000 Lux bright white light administered in the morning hours reduced fatigue by 17% in patients with cancer and that the mean fatigue scores of patients decreased from 30.37 to 9.48 compared to before the light administration. According to NCCN (2020), white light of 10,000 Lux can be applied for 30-90 minutes in the morning hours to regulate sleep and manage fatigue in the post treatment period as well as in cancer patients receiving active treatment. However, studies on this subject consist of small sample groups, and more studies are needed to identify the risks and benefits of the application and to determine the optimal application time and duration. The present study was aimed to evaluate the effect of white light on the fatigue levels of patients with gynecological cancer who were treated with chemotherapy. The patients with high levels of fatigue in every dimension were selected so as to have a homogeneous group. The research hypotheses were determined as follows: H0: White light has no effect on fatigue levels in patients with gynecological cancer. H1: White light reduces fatigue levels in patients with gynecological cancer.

Interventions

OTHERWhite Light Application

White Light Therapy

Sponsors

Eskisehir Osmangazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* had a normal state of consciousness, * had no communication disorders, did not work in the night shift, * had a general fatigue level score of ≥1 according to the Brief Fatigue Inventory

Exclusion criteria

* had natural/artificial lenses, * used medication that causes photosensitivity (tetracycline, doxycycline, nalidixic acid, voriconazole, amiodarone, hydrochlorothiazide, naproxen, piroxicam, chlorpromazine) * had a change in their treatment plan in the last 6 weeks were not included in the study

Design outcomes

Primary

MeasureTime frameDescription
White light changes general fatigue scoresgeneral fatigue levels of patients on 0., 9. and 21. daysWhite light changes general fatigue levels in patients with gynecological cancer

Secondary

MeasureTime frameDescription
White light changes activity fatigue scoresactivity fatigue levels of patients on 0., 9. and 21. daysWhite light changes activity fatigue levels in patients with gynecological cancer

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026